share_log

Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties

Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties

Aclaris Therapeutics宣佈與Sun Pharma就Deuruxolitinib的權利達成獨家專利許可協議;協議包括1500萬美元的預付款,外加里程碑和特許權使用費
Benzinga ·  2023/12/05 16:02

Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties

Aclaris Therapeutics宣佈與Sun Pharma就Deuruxolitinib的權利達成獨家專利許可協議;協議包括1500萬美元的預付款,外加里程碑和特許權使用費

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論